Zion Market Research Global Veterinary Animal Vaccines Market, 2016–202 | Page 3

Veterinary/Animal Vaccines Market
of the global market. However, the increasing maintenance prices for storage of vaccines,
growing implementation of vegetarian food in main economies due to the intensifying risk of
obesity and other several chronic disorders, constant economic slowdown are few factors
that may restrict the growth of the global veterinary/animal vaccines market.
Global Veterinary/Animal Vaccines Market: Segmentation
The global veterinary/animal vaccines market can be segmented based on technology,
disease, product, and region. The technology segment of the market is categorized into live
attenuated vaccines, recombinant vaccines, conjugate vaccines, toxoid vaccines,
inactivated vaccines, DNA vaccines, and subunit vaccines. The DNA vaccine segment of
the market is assumed to grow at the significant rate due to the technological advancements
and rising public alertness about animal vaccination. The disease segment of the market is
grouped into companion animal disease, aquaculture diseases, poultry diseases, livestock
diseases, and other diseases. The companion animal vaccines segment of the market is
expected to grow at a faster rate owing to the growing incidence of zoonotic diseases in
humans and the rising pet population. The product segment of the veterinary/animal
vaccines market is classified into porcine vaccines, equine vaccines, companion animal
vaccines, aquaculture vaccines, livestock vaccines, poultry vaccines, and other animal
vaccines. Geographically, the veterinary/animal vaccines market is categorized into Europe,
North America, Asia-Pacific, Latin America, and the Middle East & Africa.
Request Report TOC (Table of Contents) @
https://www.zionmarketresearch.com/toc/veterinary-animal-vaccines-market
Global Veterinary/Animal Vaccines Market: Regional Analysis